background
human
rhinovirusenteroviru
hrvent
infect
commonli
identifi
children
acut
respiratori
infect
ari
data
clinic
sever
remain
limit
object
compar
clinic
sever
hrvent
respiratori
syncyti
viru
rsv
influenza
ab
flu
common
respiratori
virus
children
patientsmethod
retrospect
studi
children
ari
confirm
singl
posit
viral
infect
midturbin
swab
molecular
assay
outcom
measur
includ
hospit
admiss
inpati
composit
endpoint
consist
intens
care
admiss
hospit
day
oxygen
requir
death
result
total
hrvent
rsv
flu
common
respiratori
virus
identifi
children
singl
hrvent
infect
present
significantli
higher
rate
underli
immunosuppress
condit
compar
rsv
versu
p
flu
versu
p
singl
viral
infect
versu
p
multivari
analysi
adjust
underli
condit
age
children
hrvent
infect
increas
odd
hospit
compar
children
rsv
infect
ci
p
flu
infect
ci
increas
odd
sever
clinic
diseas
among
inpati
ci
p
compar
flu
infect
conclus
children
hrvent
sever
clinic
cours
rsv
fluab
infect
often
signific
comorbid
find
emphas
import
consid
hrvent
infect
children
present
sever
acut
respiratori
tract
infect
keyword
clinic
diseas
sever
human
rhinovirusenteroviru
influenza
respiratori
syncyti
viru
singl
viral
infect
pleas
cite
paper
asner
et
al
clinic
sever
rhinovirusenteroviru
compar
respiratori
virus
children
influenza
respiratori
virus
human
rhinovirusenteroviru
hrvent
recent
identifi
lead
pathogen
acut
asthma
exacerb
bronchiol
viral
pneumonia
although
clinic
sever
respiratori
ill
attribut
hrvent
remain
uncertain
studi
conduct
among
younger
children
admit
bronchiol
report
conflict
inform
clinic
sever
hrvent
infect
possibl
result
differ
age
group
studi
studi
papadopulo
et
al
report
hrvent
signific
predictor
sever
diseas
anoth
studi
midulla
et
al
report
hrvent
bronchiol
result
less
sever
diseas
compar
rsv
bronchiol
among
infant
convers
studi
involv
older
hospit
children
consist
report
equival
diseas
sever
respiratori
ill
caus
hrvent
caus
common
respiratori
virus
explan
discrep
observ
among
studi
includ
use
differ
clinic
criteria
assess
clinic
sever
clinic
sever
score
versu
clinic
outcom
focu
differ
patient
popul
age
group
inpati
young
children
furthermor
contribut
hrvent
infect
versu
hostrel
factor
underli
immunosuppress
sever
diseas
report
studi
summari
grow
evid
hrvent
commonli
identifi
viru
lrti
adult
children
thu
need
regard
pathogen
respons
much
common
cold
object
studi
compar
clinic
characterist
sever
ill
hrventposit
children
posit
rsv
ab
flua
flub
respiratori
virus
use
larg
dataset
broad
pediatr
inpati
outpati
popul
ii
consid
sever
clinic
endpoint
assess
diseas
sever
iii
conduct
multivari
analysi
adjust
potenti
confound
variabl
conduct
singlecent
retrospect
studi
children
present
acut
respiratori
ill
singl
viral
infect
document
molecular
assay
midturbin
swab
hospit
sick
children
toronto
canada
multiplex
pcr
conduct
random
sampl
patient
present
arti
treat
physician
order
midturbin
swab
test
respiratori
virus
reli
clinic
assess
routin
done
children
respiratori
ill
includ
common
cold
pharyng
laryng
tracheiti
bronchiti
bronchiol
communityacquir
pneumonia
cap
use
dataset
microbiolog
laboratori
hospit
sick
children
origin
aim
compar
sensit
four
differ
multiplex
assay
resplex
ii
qiagen
mississauga
canada
seeplex
kit
seegen
inc
seoul
korea
xtagrvp
xtagrvp
fast
luminex
austin
tx
usa
addit
dfa
viral
cultur
result
origin
studi
recent
publish
elsewher
dataset
augment
retrospect
chart
review
children
document
viral
coinfect
ie
detect
one
viral
pathogen
sampl
exclud
inclus
would
allow
singl
viral
infect
comparison
result
abl
determin
virus
detect
lead
pathogen
data
collect
novemb
april
januari
march
time
multiplex
pcr
test
routin
util
randomli
select
patient
year
age
present
acut
respiratori
tract
infect
arti
urti
defin
detect
singl
respiratori
viral
infect
togeth
symptom
involv
upper
respiratori
tract
nose
pharynx
lrti
defin
patient
cough
tachypnea
respiratori
distress
wheez
communityacquir
pneumonia
cap
defin
lrti
symptom
pulmonari
infiltr
diagnos
chest
xray
radiologist
sever
clinic
diseas
defin
hospit
admiss
outpati
composit
endpoint
includ
intens
care
icu
admiss
hospit
day
oxygen
requir
death
patient
admit
hospit
ethic
approv
obtain
research
ethic
board
hospit
sick
children
inform
patient
demograph
relev
baselin
characterist
underli
comorbid
outcom
extract
health
record
relev
underli
comorbid
group
three
mutual
exclus
categori
cardiorespiratori
prematur
immunosuppressivemetabol
condit
one
follow
immunodefici
state
includ
latter
group
hematopoiet
stem
cell
transplant
allogen
autolog
solid
organ
transplant
sot
recipi
recipi
cancer
chemotherapi
longterm
immunosuppress
chronic
diseas
congenit
immunodefici
state
metabol
condit
includ
inherit
metabol
diseas
cystinuria
phenylketonuria
pku
gout
thyroid
diseas
case
multipl
comorbid
patient
refer
group
consid
signific
comorbid
underli
immunocompromisedmetabol
condit
consid
signific
comorbid
follow
cardiorespiratori
comorbid
outcom
consist
hospit
admiss
durat
hospit
admiss
length
day
intens
care
icu
admiss
supplement
oxygen
requir
presenc
urti
cap
allcaus
mortal
novemb
april
januari
march
midturbin
swab
floqswab
copan
italia
brescia
itali
test
respiratori
virus
randomli
select
week
among
specimen
collect
children
acut
respiratori
tract
infect
arti
submit
clinic
laboratori
routin
virolog
test
includ
molecular
assay
neither
laboratori
staff
clinician
awar
advanc
patient
would
select
viral
detect
molecular
assay
swab
assay
four
differ
nucleic
acid
amplificationbas
assay
resplex
ii
true
posit
result
defin
two
posit
test
result
among
four
molecular
assay
bacteri
coinfect
defin
presenc
bacteri
pathogen
identifi
cultur
blood
cultur
respiratori
sampl
bronchoalveolar
lavag
tracheal
secret
sputum
sampl
pleural
fluid
upon
initi
consult
respiratori
symptom
within
day
initi
consult
staphylococcu
epidermidi
posit
blood
cultur
consid
pathogen
drawn
one
peripher
blood
cultur
one
blood
cultur
drawn
central
line
one
peripher
line
highrisk
patient
underli
immunosuppress
condit
prosthet
devic
newborn
accord
recent
guidelin
addit
posit
urinari
antigen
streptococcu
pneumonia
retriev
upon
admiss
within
day
admiss
also
consid
bacteri
coinfect
posit
bacteri
urinari
stool
cultur
bacteri
pathogen
identifi
skin
wound
swab
consid
bacteri
coinfect
standard
descript
compar
statist
perform
data
categor
viral
pathogen
hrv
ent
use
refer
compar
rsv
flu
categori
consist
common
virus
includ
piv
hmpv
hbov
adv
coronavirus
chisquar
test
fisher
exact
test
use
compar
categor
variabl
group
appropri
multivari
logist
regress
use
compar
clinic
correl
clinic
diseas
sever
children
infect
hrvent
infect
either
rsv
flu
common
singl
respiratori
virus
deriv
median
use
mannwhitney
nonparametr
method
comparison
nonnorm
distribut
continu
data
use
transform
use
natur
logarithm
ln
outcom
variabl
perform
multivari
linear
regress
twosid
test
perform
p
valu
consid
statist
signific
data
analyz
use
spss
statist
softwar
version
spss
inc
chicago
il
usa
total
children
evalu
respiratori
ill
screen
respiratori
virus
midturbin
swab
molecular
assay
studi
period
children
detect
posit
respiratori
viru
among
patient
admit
among
inpati
present
sever
diseas
total
two
respiratori
virus
exclud
analys
remain
test
posit
singl
respiratori
viru
hrvent
rsv
flu
respiratori
virus
rate
overal
bacteri
coinfect
low
among
inpati
children
singl
hrvent
infect
significantli
older
compar
singl
rsv
infect
median
age
year
versu
year
p
children
hrvent
infect
present
significantli
higher
rate
underli
cardiorespiratori
comorbid
compar
children
rsv
versu
ci
p
flu
versu
ci
p
singl
viral
infect
versu
ci
p
tabl
children
hrvent
infect
significantli
higher
rate
pneumonia
compar
rsv
versu
ci
p
compar
children
rsv
infect
flu
infect
hrvent
infect
significantli
higher
admiss
rate
versu
respect
p
among
children
admit
hospit
hrvent
infect
increas
length
stay
compar
flu
infect
day
iqr
versu
day
iqr
day
p
six
children
die
four
present
hrvent
infect
one
present
progress
acut
respiratori
distress
syndrom
ard
adv
infect
die
week
flua
infect
remain
one
present
hbov
infect
four
fatal
hrvent
infect
three
present
underli
immunosuppress
condit
one
cardiac
comorbid
two
patient
die
sepsislik
pictur
respiratori
failur
possibl
underli
pneumonia
pathogen
identifi
thu
suggest
hrvent
may
potenti
contribut
mortal
remain
two
patient
like
die
underli
diseas
tabl
multivari
analysi
adjust
age
comorbid
identifi
children
hrvent
infect
significantli
like
hospit
compar
rsv
infect
ci
p
flu
infect
ci
tabl
furthermor
age
per
year
ci
p
underli
immunosuppressivemetabol
condit
ci
p
signific
predictor
hospit
admiss
interact
term
measur
combin
hrventposit
statu
underli
immunocompromis
condit
signific
inclus
affect
risk
estim
post
hoc
analyz
conduct
among
patient
underli
immunosuppress
condit
affect
risk
estim
although
result
human
rhinovirusenterovirusinfect
children
significantli
like
present
sever
clinic
diseas
multivari
analysi
compar
children
admit
hospit
flu
infect
ci
p
tabl
children
admit
hrvent
infect
increas
length
stay
compar
admit
flu
infect
b
coeffici
ci
p
multivari
analysi
logarithm
admiss
length
use
outcom
variabl
children
underli
immunosuppress
metabol
state
increas
length
admiss
compar
without
underli
immunosuppress
metabol
condit
b
coeffici
ci
p
tabl
three
import
observ
made
studi
hrvent
acut
respiratori
infect
commonli
detect
patient
popul
children
hrvent
infect
sever
outcom
compar
common
respiratori
virus
children
underli
cardiorespiratori
immunocompromisedmetabol
condit
like
present
hrvent
infect
proport
singl
hrvent
infect
report
studi
significantli
higher
studi
use
convent
diagnost
method
compar
molecular
test
use
includ
studi
children
arti
hrvent
enterovirusrhinoviru
rsv
respiratori
syncyti
viru
flu
influenza
other
piv
parainfluenza
hmpv
human
metapneumoviru
adv
adenoviru
coronavirus
hbov
valu
indic
bold
consid
signific
p
hrvent
enterovirusrhinoviru
rsv
respiratori
syncyti
viru
flu
influenza
other
piv
parainfluenza
hmpv
human
metapneumoviru
adv
adenoviru
coronavirus
hbov
valu
indic
bold
consid
signific
p
infant
bronchiol
discrep
attribut
higher
sensit
broader
rang
viru
detect
molecularbas
method
similar
other
studi
children
infect
hrv
ent
alon
younger
compar
flu
infect
older
compar
rsv
infect
studi
children
hrvent
infect
present
higher
rate
underli
cardiorespiratori
immunosuppress
condit
compar
singl
viral
infect
find
similar
describ
adult
admit
hrvent
respiratori
infect
high
rate
underli
immunosuppress
condit
identifi
thu
suggest
patient
may
higher
risk
hrvent
infect
extent
sever
respiratori
ill
attribut
hrvent
underli
condit
yet
unclear
notwithstand
high
proport
underli
comorbid
identifi
among
hrvent
popul
hrv
entposit
statu
identifi
signific
independ
predictor
hospit
admiss
result
increas
clinic
diseas
sever
among
inpati
compar
either
rsv
flu
control
underli
comorbid
age
furthermor
found
significantli
longer
durat
hospit
among
children
admit
hrvent
infect
compar
admit
flu
infect
also
higher
rate
pneumonia
observ
among
children
singl
hrvent
infect
compar
rsv
singl
viral
infect
suggest
previou
studi
malcolm
et
al
final
half
death
observ
among
four
hrventinfect
children
underli
condit
may
result
hrv
ent
respiratori
ill
viral
bacteri
fungal
pathogen
document
find
contrast
recent
publish
studi
report
equival
diseas
sever
subject
hrvent
infect
common
viral
infect
studi
howev
major
limit
may
result
detect
true
differ
firstli
studi
conduct
inpati
one
specul
hospit
patient
share
level
comorbid
lead
similar
outcom
regardless
viru
involv
furthermor
studi
compar
hrvent
infect
virus
combin
adjust
underli
comorbid
treatment
fluaposit
children
oseltamivir
might
expect
improv
prognosi
children
includ
studi
receiv
oseltamivir
specimen
collect
implement
guidelin
advoc
oseltamivir
treatment
highrisk
children
thu
differ
outcom
hrvent
treat
flua
may
even
pronounc
found
studi
import
strength
studi
inclus
outpati
thu
enabl
use
hospit
admiss
measur
clinic
sever
furthermor
adjust
underli
comorbid
multivari
analysi
reinforc
associ
hrvent
clinic
outcom
given
low
rate
bacteri
coinfect
adjust
variabl
made
multivari
analys
final
adequ
sampl
size
compar
hrvent
number
differ
virus
potenti
limit
studi
relat
retrospect
design
howev
believ
patientrel
import
outcom
could
well
assess
though
chart
review
similarli
observ
natur
studi
may
led
select
bia
consecut
patient
test
respiratori
virus
result
limit
resourc
random
sampl
ensur
unbias
select
sampl
test
molecular
assay
furthermor
criteria
use
virolog
diagnost
part
routin
patient
care
may
vari
studi
instanc
viral
cultur
routin
use
novemb
april
may
affect
comparison
ill
sever
differ
virus
third
assess
presenc
absenc
virus
measur
viral
load
higher
viral
load
acut
ill
subject
compar
asymptomat
children
might
strengthen
associ
hrvent
sever
diseas
rhinovirus
also
commonli
identifi
communitybas
control
futur
research
measur
viral
load
use
sequenc
genotyp
analysi
differenti
hrv
enteroviru
speciat
hrv
recent
studi
suggest
human
rhinoviru
speci
c
hrva
hrvc
may
associ
greater
clinic
sever
compar
hrvb
speci
final
estim
bacteri
coinfect
may
underestim
adequ
respiratori
sampl
bal
rare
perform
children
pneumonia
rare
result
posit
blood
cultur
also
urt
sampl
necessarili
repres
lrt
diseas
limit
inher
studi
assess
sever
respiratori
ill
children
may
overcom
futur
prospect
studi
conduct
among
children
specif
underli
comorbid
eg
immunocompromis
children
would
includ
valid
molecular
assay
detect
viral
bacteri
pathogen
urt
sampl
children
arti
conclus
find
provid
new
insight
burden
sever
hrvent
infect
reinforc
need
routin
diagnosi
hospit
set
hrvent
infect
common
associ
sever
diseas
common
virus
flu
rsv
highlight
need
develop
test
specif
antivir
drug
